Skip to content
Assyro AI
Back to Glossary
General

ICH(International Council for Harmonisation)

ICH is the global standards body where pharmaceutical regulators and industry associations jointly draft technical guidelines for drug quality, safety, and efficacy; it enacts no law itself, so guidelines apply only once a member authority adopts them.

Usage Examples

  • Our stability package still runs on the current final ICH stability guidances; the consolidated Q1 revision is only a draft.
  • The reviewer flagged Module 2.3 because it does not follow the ICH M4 granularity structure.
  • Rewrite the monitoring plan against ICH E6(R3) principles and Annex 1, and leave Annex 2 out until it is final.

What is ICH (International Council for Harmonisation)?

ICH is the global standards body where pharmaceutical regulators and industry associations jointly draft technical guidelines for drug quality, safety, and efficacy; it enacts no law itself, so guidelines apply only once a member authority adopts them.

ICH exists to stop the same drug data being repackaged three ways. FDA's notice announcing the M4 Common Technical Document said the harmonized format was intended to reduce the time and resources used to compile applications and simplify the exchange of regulatory information among regulatory authorities. ICH is the forum where regulators and industry settle that standard before any authority writes it into national guidance.

ICH covers technical requirements for human pharmaceuticals, sorted into four series: Quality (Q9(R1) Quality Risk Management), Safety (S12 Nonclinical Biodistribution), Efficacy (E6(R3) Good Clinical Practice), and Multidisciplinary (M4, M11, M15). ICH's remit is fixed by its full name, Technical Requirements for Pharmaceuticals for Human Use, so veterinary products go to VICH and devices sit outside both. ICH has no enforcement arm: no ICH inspector, no ICH finding.

ICH is applied through the instrument that adopted it, not by citing ICH directly. In the US that instrument is an FDA guidance for industry announced in the Federal Register: E6(R3) Good Clinical Practice carries a US date of September 9, 2025, and M15 June 3, 2026. ICH-literate teams track the adopting authority and its date, not the ICH number.

Not to be confused with

CTD / eCTD
the CTD is a deliverable ICH produced under M4, not ICH itself. ICH is the body, the CTD is the dossier structure it defined, and the eCTD is the electronic format that carries that structure to the agency.
VICH
VICH is the veterinary counterpart, the International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products. FDA issues VICH texts as guidances for industry for animal drugs, so an ICH citation in a veterinary file points at the wrong body.
FDA guidance
FDA guidance is the US instrument that gives an ICH guideline effect. The two texts are usually near-identical, but only the FDA document is what a US reviewer works from, and it exists only after FDA adopts the guideline.
International Conference on Harmonisation
the former name of the same organization. FDA's 2017 M4 notice records ICH as "formerly the International Conference on Harmonisation," so pre-change documents say Conference and current ones say Council.

ICH imposes nothing directly. These are the anchor guidelines FDA has adopted, and the obligations follow from the adopted FDA text.

What you must do

  1. 1Assemble marketing applications in the Common Technical Document structure, including the Granularity Document Annex, Module 2.3 Quality Overall Summary, and Module 3 Quality as revised in October 2017ICH M4
  2. 2Run clinical trials against the principles document and Annex 1, applying quality-by-design, proportionality, and risk-based approaches, and treat Annex 2 as draft until FDA finalizes itICH E6(R3)
  3. 3Base stability commitments on the current final stability guidances, and do not rebuild protocols around the consolidated Q1 revision that FDA issued as a draft on June 24, 2025ICH Q1A(R2)
  4. 4Apply quality risk management as an explicit, documented process, per the revision FDA adopted on May 4, 2023ICH Q9(R1)
  5. 5Document model-informed drug development evidence to the harmonized assessment framework and its terminology whenever MIDD supports a regulatory questionICH M15

Common mistakes

  • Citing the ICH number instead of the adopted FDA guidance

    ICH publishes the text, but the instrument in a US submission is FDA's guidance for industry announced in the Federal Register. Quoting an ICH guideline FDA has not adopted writes a requirement into your dossier that no US reviewer is working from, and it invites a question you cannot answer.

  • Building procedures on a draft

    FDA issued the consolidated Q1 stability guidance as a draft on June 24, 2025 and E6(R3) Annex 2 as a draft on December 30, 2024. A stability protocol or a decentralized-trial SOP written against draft text has to be rewritten when the final version lands, and any batch or trial data already generated under it is stranded.

  • Assuming ICH covers everything you file

    ICH's scope is pharmaceuticals for human use. Veterinary products harmonize through VICH, and medical devices fall outside both. Mapping a device or animal-health program onto ICH modules produces a dossier the receiving center cannot process, which costs a full refile cycle.

When This Matters

  • Our stability package still runs on the current final ICH stability guidances; the consolidated Q1 revision is only a draft.
  • The reviewer flagged Module 2.3 because it does not follow the ICH M4 granularity structure.
  • Rewrite the monitoring plan against ICH E6(R3) principles and Annex 1, and leave Annex 2 out until it is final.

Frequently Asked Questions

No. ICH guidelines carry no legal force on their own; they apply to a sponsor only once a member authority adopts them. In the United States, FDA implements each one as a guidance for industry announced in the Federal Register, such as E6(R3) Good Clinical Practice on September 9, 2025.

Related Use Cases

Related Regulatory Intelligence

Related Actions

Sources & References

Share this page
Agent CTA Background

Simplify International Council for Harmonisation compliance

Book a Demo